Form 4 for ABT Abbott Laboratories
Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-14 · accession 0001415889-23-016642 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-18 | 2023-12-14 | ABT | Wainer Andrea F | EVP | M - OptEx | $44.40 | +15.0K | 80.0K | +23% | +$666.0K |
| D | 2023-12-18 | 2023-12-14 | ABT | Wainer Andrea F | EVP | S - Sale+OE | $108.00 | -15.0K | 65.0K | -19% | -$1.62M |
| D | 2023-12-18 | 2023-12-14 | ABT | Wainer Andrea F | EVP | M - OptEx | $0.00 | -15.0K | 38.3K | -28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2023-12-14 | M | A | 15,000 | $44.40 | 80,027 | D | — | — | |
| 2 | Common | Common shares without par value | 2023-12-14 | S | D | 15,000 | $108.00 | 65,027 | D | — | — | |
| 3 | Derivative | Option (right to buy) | 2023-12-14 | M | D | 15,000 | $0.00 | 38,271 | D | $44.40 · 2020-02-17 to 2027-02-16 | 15,000 Common Shares | (F1) Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |